These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 33318429)
1. Dopaminergic-cholinergic imbalance in movement disorders: a role for the novel striatal dopamine D Crans RAJ; Ciruela F Neural Regen Res; 2021 Jul; 16(7):1406-1408. PubMed ID: 33318429 [No Abstract] [Full Text] [Related]
2. Dopaminergic and cholinergic interaction in cataleptic responses in mice. Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077 [TBL] [Abstract][Full Text] [Related]
3. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia. Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876 [TBL] [Abstract][Full Text] [Related]
5. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease. Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457 [TBL] [Abstract][Full Text] [Related]
6. Cortical and nigral deafferentation and striatal cholinergic markers in the rat dorsal striatum: different effects on the expression of mRNAs encoding choline acetyltransferase and muscarinic m1 and m4 receptors. Kayadjanian N; Schofield WN; Andren J; Sirinathsinghji DJ; Besson MJ Eur J Neurosci; 1999 Oct; 11(10):3659-68. PubMed ID: 10564373 [TBL] [Abstract][Full Text] [Related]
7. Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat. Alcantara AA; Chen V; Herring BE; Mendenhall JM; Berlanga ML Brain Res; 2003 Oct; 986(1-2):22-9. PubMed ID: 12965226 [TBL] [Abstract][Full Text] [Related]
8. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons. Dawson VL; Dawson TM; Wamsley JK Brain Res Bull; 1990 Dec; 25(6):903-12. PubMed ID: 2149667 [TBL] [Abstract][Full Text] [Related]
9. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment. Joyce JN Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220 [TBL] [Abstract][Full Text] [Related]
10. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Gerber DJ; Sotnikova TD; Gainetdinov RR; Huang SY; Caron MG; Tonegawa S Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15312-7. PubMed ID: 11752469 [TBL] [Abstract][Full Text] [Related]
11. The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's disease. Efange SM; Langason RB; Khare AB; Low WC Life Sci; 1996; 58(16):1367-74. PubMed ID: 8614294 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats. Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685 [TBL] [Abstract][Full Text] [Related]
14. Striatal cholinergic transmission. Focus on nicotinic receptors' influence in striatal circuits. Assous M Eur J Neurosci; 2021 Apr; 53(8):2421-2442. PubMed ID: 33529401 [TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate-evoked release of [3H]acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA. Blanchet F; Kemel ML; Gauchy C; Desban M; Perez S; Glowinski J Neuroscience; 1997 Nov; 81(1):113-27. PubMed ID: 9300405 [TBL] [Abstract][Full Text] [Related]
17. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum. Harsing LG; Zigmond MJ Brain Res Bull; 1998 Apr; 45(6):607-13. PubMed ID: 9566505 [TBL] [Abstract][Full Text] [Related]
18. Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression. Mavridis M; Rogard M; Besson MJ Neuroscience; 1995 May; 66(1):37-53. PubMed ID: 7637873 [TBL] [Abstract][Full Text] [Related]
19. M1 muscarinic acetylcholine receptor-mediated inhibition of GABA release from striatal medium spiny neurons onto cholinergic interneurons. Suzuki E; Momiyama T Eur J Neurosci; 2021 Feb; 53(3):796-813. PubMed ID: 33270289 [TBL] [Abstract][Full Text] [Related]
20. Sustained unilateral blockade of rat striatal M(1) muscarinic receptors with m1-toxin1 in vivo. Liang J; Gutierrez-Ford C; Potter LT Brain Res; 2001 Dec; 921(1-2):211-8. PubMed ID: 11720728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]